JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.04% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.55% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4976
Sprott Physical Gold and Silver Trust
CEF
$8.23B
| $149K | ﹤0.01% |
8,847
-527
| -6% | -$9.56K |
|
4977
Cenntro
CENN
$8.63M
| $149K | ﹤0.01% |
164
-1,362
| -89% | -$1.44M |
|
|
DBD
4978
DELISTED
Diebold Nixdorf Incorporated
DBD
| $149K | ﹤0.01% |
65,264
+2,330
| +4% | +$8.68K |
|
|
KBAL
4979
DELISTED
Kimball International
KBAL
| $149K | ﹤0.01% |
19,408
+2,237
| +13% | +$18.3K |
|
|
YELL
4980
DELISTED
Yellow Corporation Common Stock
YELL
| $149K | ﹤0.01% |
50,772
-98,504
| -66% | -$400K |
|
|
FMTX
4981
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $148K | ﹤0.01% |
21,549
-114
| -0.5% | -$800 |
|
4982
Kodak
KODK
$979M
| $147K | ﹤0.01% |
31,739
+9,587
| +43% | +$50K |
|
|
STR
4983
DELISTED
Sitio Royalties
STR
| $147K | ﹤0.01% |
6,307
-129,309
| -95% | -$3.58M |
|
4984
CALL
Truist Financial
TFC
$64.9B
| $147K | ﹤0.01% |
3,100
| – | – |
|
|
VTYX
4985
DELISTED
Ventyx Biosciences
VTYX
| $147K | ﹤0.01% |
11,984
+4,391
| +58% | +$65.6K |
|
|
APTX
4986
DELISTED
Aptinyx Inc. Common Stock
APTX
| $147K | ﹤0.01% |
263,954
| – | – |
|
4987
Vita Coco
COCO
$3.77B
| $146K | ﹤0.01% |
14,907
+9,639
| +183% | +$102K |
|
|
CPAC
4988
Cementos Pacasmayo
CPAC
$1.02B
| $146K | ﹤0.01% |
31,025
| – | – |
|
4989
iShares MSCI Italy ETF
EWI
$1.08B
| $146K | ﹤0.01% |
6,048
-138,726
| -96% | -$3.8M |
|
4990
Foghorn Therapeutics
FHTX
$372M
| $146K | ﹤0.01% |
10,744
+1,570
| +17% | +$20.3K |
|
4991
SES AI
SES
$223M
| $146K | ﹤0.01% |
37,175
+20,630
| +125% | +$132K |
|
4992
Fidelity MSCI Materials Index ETF
FMAT
$614M
| $145K | ﹤0.01% |
3,532
-332
| -9% | -$15.6K |
|
4993
IES Holdings
IESC
$15.1B
| $145K | ﹤0.01% |
4,822
-1,782
| -27% | -$57.3K |
|
|
DOMA
4994
DELISTED
Doma Holdings, Inc.
DOMA
| $144K | ﹤0.01% |
5,599
+1,837
| +49% | +$78.1K |
|
|
OTLY
4995
Oatly Group
OTLY
$441M
| $143K | ﹤0.01% |
2,064
-3,636
| -64% | -$284K |
|
4996
Aterian
ATER
$5.44M
| $142K | ﹤0.01% |
5,491
+4,476
| +441% | +$198K |
|
4997
Vanguard Total World Bond ETF
BNDW
$1.89B
| $142K | ﹤0.01% |
+2,030
| New | +$144K |
|
4998
Centrus Energy
LEU
$3.79B
| $142K | ﹤0.01% |
5,741
+1,143
| +25% | +$31.6K |
|
4999
Lindblad Expeditions
LIND
$2.2B
| $142K | ﹤0.01% |
17,514
+2,858
| +20% | +$37.2K |
|
5000
Offerpad Solutions
OPAD
$21.5M
| $142K | ﹤0.01% |
434
+431
| +14,367% | +$289K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.